{"transactions":[{"id":932459,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-23T18:10:48.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":2689,"price":1.8838,"value":5065.5382,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.8700 to $1.9000. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":881275,"source":{"system":"sec-edgar","filing":"0001628280-26-003346","document":"wk-form4_1769209845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026003346/wk-form4_1769209845.xml","form_type":"4"}},{"id":932458,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-23T18:10:48.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":9346,"price":1.8112,"value":16927.4752,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7600 to $1.8800. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":883964,"source":{"system":"sec-edgar","filing":"0001628280-26-003346","document":"wk-form4_1769209845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026003346/wk-form4_1769209845.xml","form_type":"4"}},{"id":934367,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-21T18:32:39.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":450000,"derivative":{"exercise_price":1.86,"expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001628280-26-002962","document":"wk-form4_1769038356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026002962/wk-form4_1769038356.xml","form_type":"4"}},{"id":934366,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-21T18:32:39.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":299800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":893310,"source":{"system":"sec-edgar","filing":"0001628280-26-002962","document":"wk-form4_1769038356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026002962/wk-form4_1769038356.xml","form_type":"4"}},{"id":941129,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-12T18:50:33.000Z","date":"2026-01-12","kind":"sale","planned":false,"acquired":false,"shares":5388,"price":1.7273,"value":9306.6924,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.6700 to $1.8400. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":593510,"source":{"system":"sec-edgar","filing":"0001628280-26-001895","document":"wk-form4_1768261820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026001895/wk-form4_1768261820.xml","form_type":"4"}},{"id":941128,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-12T18:50:33.000Z","date":"2026-01-09","kind":"sale","planned":false,"acquired":false,"shares":12941,"price":1.7643,"value":22831.8063,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7100 to $1.8100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":598898,"source":{"system":"sec-edgar","filing":"0001628280-26-001895","document":"wk-form4_1768261820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026001895/wk-form4_1768261820.xml","form_type":"4"}},{"id":941127,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-12T18:50:33.000Z","date":"2026-01-08","kind":"sale","planned":false,"acquired":false,"shares":8143,"price":1.8194,"value":14815.3742,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.8700. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":611839,"source":{"system":"sec-edgar","filing":"0001628280-26-001895","document":"wk-form4_1768261820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026001895/wk-form4_1768261820.xml","form_type":"4"}},{"id":944725,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:07.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":37755,"price":1.986,"value":74981.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0300. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":619982,"source":{"system":"sec-edgar","filing":"0001628280-26-001263","document":"wk-form4_1767839464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026001263/wk-form4_1767839464.xml","form_type":"4"}},{"id":944724,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:07.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":5102,"price":1.9662,"value":10031.5524,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $2.0000. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":657737,"source":{"system":"sec-edgar","filing":"0001628280-26-001263","document":"wk-form4_1767839464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026001263/wk-form4_1767839464.xml","form_type":"4"}},{"id":944723,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:07.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":4649,"price":1.971,"value":9163.179,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9000 to $2.0600. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":662839,"source":{"system":"sec-edgar","filing":"0001628280-26-001263","document":"wk-form4_1767839464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000162828026001263/wk-form4_1767839464.xml","form_type":"4"}},{"id":1296505,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-23T17:18:02.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":12619,"price":1.593,"value":20102.067,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.5700 to $1.6100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":667488,"source":{"system":"sec-edgar","filing":"0001576885-25-000035","document":"wk-form4_1737670677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000157688525000035/wk-form4_1737670677.xml","form_type":"4"}},{"id":1308260,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-07T20:09:04.000Z","date":"2025-01-07","kind":"grant","planned":true,"acquired":true,"shares":338000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":338000,"derivative":{"exercise_price":1.83,"expiration_date":"2035-01-07","underlying":"Common Stock","underlying_shares":338000},"source":{"system":"sec-edgar","filing":"0001576885-25-000021","document":"wk-form4_1736298537.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000157688525000021/wk-form4_1736298537.xml","form_type":"4"}},{"id":1308259,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-07T20:09:04.000Z","date":"2025-01-07","kind":"grant","planned":true,"acquired":true,"shares":225400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an RSU award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":680107,"source":{"system":"sec-edgar","filing":"0001576885-25-000021","document":"wk-form4_1736298537.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000157688525000021/wk-form4_1736298537.xml","form_type":"4"}},{"id":1308258,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-07T20:09:04.000Z","date":"2025-01-03","kind":"sale","planned":true,"acquired":false,"shares":47778,"price":1.8392,"value":87873.2976,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7772 to $1.9150. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":454707,"source":{"system":"sec-edgar","filing":"0001576885-25-000021","document":"wk-form4_1736298537.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000157688525000021/wk-form4_1736298537.xml","form_type":"4"}},{"id":1675396,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-19T19:07:42.000Z","date":"2024-01-19","kind":"sale","planned":true,"acquired":false,"shares":15200,"price":3.4706,"value":52753.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.3950 to $3.6500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":502485,"source":{"system":"sec-edgar","filing":"0001576885-24-000029","document":"wk-form4_1705709243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000157688524000029/wk-form4_1705709243.xml","form_type":"4"}},{"id":1688290,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-04T16:18:22.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":602000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":602000,"derivative":{"exercise_price":4.23,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":602000},"source":{"system":"sec-edgar","filing":"0001576885-24-000009","document":"wk-form4_1704403087.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000157688524000009/wk-form4_1704403087.xml","form_type":"4"}},{"id":1688289,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-04T16:18:22.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":401000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":517685,"source":{"system":"sec-edgar","filing":"0001576885-24-000009","document":"wk-form4_1704403087.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000157688524000009/wk-form4_1704403087.xml","form_type":"4"}},{"id":2052703,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-18T16:22:24.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":472500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":472500,"derivative":{"exercise_price":6.11,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":472500},"source":{"system":"sec-edgar","filing":"0001209191-23-003741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919123003741/doc4.xml","form_type":"4"}},{"id":2052702,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-18T16:22:24.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":114000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":116685,"source":{"system":"sec-edgar","filing":"0001209191-23-003741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919123003741/doc4.xml","form_type":"4"}},{"id":2428864,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-21T16:20:08.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":455000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on January 19, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":455000,"derivative":{"exercise_price":5.19,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":455000},"source":{"system":"sec-edgar","filing":"0001209191-22-004419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919122004419/doc4.xml","form_type":"4"}},{"id":2489071,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-02T16:41:28.000Z","date":"2021-11-30","kind":"exercise","acquired":false,"shares":1118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.47,"expiration_date":"2021-12-01","underlying":"Common Stock","underlying_shares":1118},"source":{"system":"sec-edgar","filing":"0001209191-21-067613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919121067613/doc4.xml","form_type":"4"}},{"id":2489070,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-02T16:41:28.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":1118,"price":4.47,"value":4997.46,"ownership":{"direct":true},"balance_after":2685,"source":{"system":"sec-edgar","filing":"0001209191-21-067613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919121067613/doc4.xml","form_type":"4"}},{"id":2638492,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrant (Right to Buy)","published_at":"2021-07-08T18:16:31.000Z","date":"2021-07-06","kind":"exercise","acquired":false,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.47,"exercise_date":"2020-12-31","expiration_date":"2025-06-30","underlying":"Common Stock","underlying_shares":35},"source":{"system":"sec-edgar","filing":"0001209191-21-046029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919121046029/doc4.xml","form_type":"4"}},{"id":2638491,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Preferred Stock","published_at":"2021-07-08T18:16:31.000Z","date":"2021-07-06","kind":"exercise","acquired":false,"shares":123,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 6, 2021, each share of Series A Convertible Preferred Stock (the \"Preferred Stock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 6, 2021, each share of Series A Convertible Preferred Stock (the \"Preferred Stock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 6, 2021, each share of Series A Convertible Preferred Stock (the \"Preferred Stock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 6, 2021, each share of Series A Convertible Preferred Stock (the \"Preferred Stock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":123},"source":{"system":"sec-edgar","filing":"0001209191-21-046029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919121046029/doc4.xml","form_type":"4"}},{"id":2638490,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-08T18:16:31.000Z","date":"2021-07-06","kind":"tax_withholding","acquired":false,"shares":10,"price":16,"value":160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 6, 2021, the reporting person exercised a warrant to purchase 35 shares of ABOS common stock for $4.47 a share. The reporting person paid the exercise price on a cashless basis, resulting in ABOS's withholding of 10 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 25 shares."}],"balance_after":1567,"source":{"system":"sec-edgar","filing":"0001209191-21-046029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919121046029/doc4.xml","form_type":"4"}},{"id":2638489,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-08T18:16:31.000Z","date":"2021-07-06","kind":"other","acquired":true,"shares":35,"price":4.47,"value":156.45,"ownership":{"direct":true},"balance_after":1577,"source":{"system":"sec-edgar","filing":"0001209191-21-046029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919121046029/doc4.xml","form_type":"4"}},{"id":2638488,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68912,"kind":"person","name":"OConnell Daniel Joseph","position":1,"cik":"0001865136","reported_name":"OConnell Daniel Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-08T18:16:31.000Z","date":"2021-07-06","kind":"exercise","acquired":true,"shares":123,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 6, 2021, each share of Series A Convertible Preferred Stock (the \"Preferred Stock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":1542,"source":{"system":"sec-edgar","filing":"0001209191-21-046029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865136/000120919121046029/doc4.xml","form_type":"4"}}]}